Paid Clinical Trials and Focus Groups by Category |
|
|
|
Condition: Renal Impairment
Interventions: Drug: Febuxostat; Drug: Febuxostat; Drug: Placebo
Sponsor: Takeda Global Research & Development Center, Inc.
Not yet recruiting - verified March 2010
Condition: Constipation-predominant Irritable Bowel Syndrome
Intervention: Drug: Lubiprostone
Sponsors: Cedars-Sinai Medical Center; Takeda Pharmaceuticals North America, Inc.
Not yet recruiting - verified December 2009
Condition: Joint Damage
Interventions: Drug: Febuxostat; Drug: Placebo
Sponsor: Takeda Global Research & Development Center, Inc.
Not yet recruiting - verified February 2010
Condition: Hypertension
Interventions: Drug: Azilsartan medoxomil (TAK-491); Drug: Azilsartan medoxomil (TAK-491); Drug: Azilsartan medoxomil (TAK-491); Drug: Azilsartan medoxomil (TAK-491)
Sponsor: Takeda Global Research & Development Center, Inc.
Not yet recruiting - verified February 2010
Conditions: Hyperuricosuria; Kidney Stones
Interventions: Drug: Febuxostat; Drug: Allopurinol; Drug: Placebo
Sponsor: Takeda Global Research & Development Center, Inc.
Not yet recruiting - verified February 2010